Explainable AI enables clinical trial patient selection to retrospectively improve treatment effects in schizophrenia
Monika S. Mellem, Matt Kollada, Jane Tiller, Thomas Lauritzen
doi: https://doi.org/10.1101/2021.01.11.20248788
Monika S. Mellem
BlackThorn Therapeutics, 780 Brannan St., San Francisco, CA 94103
Matt Kollada
BlackThorn Therapeutics, 780 Brannan St., San Francisco, CA 94103
Jane Tiller
BlackThorn Therapeutics, 780 Brannan St., San Francisco, CA 94103
Thomas Lauritzen
BlackThorn Therapeutics, 780 Brannan St., San Francisco, CA 94103
Posted March 13, 2021.
Explainable AI enables clinical trial patient selection to retrospectively improve treatment effects in schizophrenia
Monika S. Mellem, Matt Kollada, Jane Tiller, Thomas Lauritzen
medRxiv 2021.01.11.20248788; doi: https://doi.org/10.1101/2021.01.11.20248788
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2946)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12752)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4587)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4361)
- Nursing (236)
- Nutrition (639)
- Oncology (2271)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6944)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)